HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Li Selected Research

Blue cone monochromatism

1/2019Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.
3/2018Publisher Correction: Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.
1/2018Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.
1/2017Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Li Research Topics

Disease

987Neoplasms (Cancer)
12/2024 - 01/2002
194Inflammation (Inflammations)
06/2024 - 05/2003
186Neoplasm Metastasis (Metastasis)
04/2024 - 06/2002
185Infections
12/2024 - 06/2002
156Breast Neoplasms (Breast Cancer)
05/2024 - 01/2002
144Hepatocellular Carcinoma (Hepatoma)
03/2024 - 02/2002
95Carcinogenesis
05/2024 - 01/2002
79Hypoxia (Hypoxemia)
04/2024 - 06/2002
73Stroke (Strokes)
04/2024 - 10/2002
67Fibrosis (Cirrhosis)
06/2024 - 03/2009
66COVID-19
02/2024 - 01/2020
65Lung Neoplasms (Lung Cancer)
05/2024 - 01/2005
60Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 11/2008
59Stomach Neoplasms (Stomach Cancer)
12/2024 - 09/2007
58Wounds and Injuries (Trauma)
05/2024 - 01/2003
54Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 05/2003
53Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 08/2010
52Carcinoma (Carcinomatosis)
05/2024 - 06/2002
52Pain (Aches)
04/2024 - 06/2007
50Prostatic Neoplasms (Prostate Cancer)
04/2024 - 12/2004
48Hypertension (High Blood Pressure)
01/2024 - 01/2004
47Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 08/2007
47Obesity
04/2024 - 03/2008
44Glioma (Gliomas)
05/2024 - 07/2004
41Ischemic Stroke
04/2024 - 09/2004
40Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 01/2013
39Insulin Resistance
01/2024 - 05/2002
38Body Weight (Weight, Body)
01/2024 - 02/2005
38Adenocarcinoma
11/2023 - 02/2003
37Alzheimer Disease (Alzheimer's Disease)
03/2024 - 06/2004
35Type 2 Diabetes Mellitus (MODY)
04/2024 - 05/2002
34Atherosclerosis
05/2024 - 01/2007
34Ischemia
03/2024 - 10/2002
34Colonic Neoplasms (Colon Cancer)
02/2024 - 06/2008
34Parkinson Disease (Parkinson's Disease)
01/2023 - 01/2002
32Osteoporosis
01/2024 - 12/2009
29Chronic Hepatitis B
04/2024 - 11/2010
29Necrosis
12/2023 - 12/2010
28Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023 - 07/2009
27Non-alcoholic Fatty Liver Disease
04/2024 - 07/2015
27Infarction (Infarctions)
04/2024 - 10/2002
27Leukemia
03/2024 - 02/2007
27Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 09/2010
27Glioblastoma (Glioblastoma Multiforme)
01/2024 - 05/2005
27Liver Neoplasms (Liver Cancer)
12/2023 - 06/2002
27Mitochondrial Diseases (Mitochondrial Disease)
11/2023 - 08/2014
26Schizophrenia (Dementia Praecox)
05/2024 - 05/2013
25Liver Cirrhosis (Hepatic Cirrhosis)
06/2024 - 01/2011
25Heart Failure
02/2024 - 12/2010
25Sepsis (Septicemia)
01/2024 - 09/2012
25Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 01/2002

Drug/Important Bio-Agent (IBA)

353Proteins (Proteins, Gene)FDA Link
12/2024 - 01/2002
240Biomarkers (Surrogate Marker)IBA
12/2024 - 03/2003
123MicroRNAs (MicroRNA)IBA
02/2024 - 07/2010
119Messenger RNA (mRNA)IBA
03/2024 - 01/2002
80Long Noncoding RNAIBA
02/2024 - 01/2014
77Glucose (Dextrose)FDA LinkGeneric
05/2024 - 05/2002
74CytokinesIBA
04/2024 - 12/2002
71EnzymesIBA
01/2024 - 07/2002
70RNA (Ribonucleic Acid)IBA
12/2024 - 06/2002
67DNA (Deoxyribonucleic Acid)IBA
04/2024 - 10/2003
64Therapeutic UsesIBA
04/2024 - 05/2003
58LipidsIBA
05/2024 - 05/2003
46Interleukin-6 (Interleukin 6)IBA
05/2024 - 12/2007
46Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 11/2006
45Cisplatin (Platino)FDA LinkGeneric
01/2024 - 05/2003
45Oxygen (Dioxygen)IBA
12/2023 - 12/2009
43AntioxidantsIBA
05/2024 - 08/2006
41Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 06/2002
40Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 06/2005
38Peptides (Polypeptides)IBA
02/2024 - 06/2004
38Phosphotransferases (Kinase)IBA
01/2023 - 05/2003
37Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 09/2003
36Insulin (Novolin)FDA Link
01/2024 - 05/2002
35CollagenIBA
04/2024 - 04/2002
34AntigensIBA
04/2024 - 08/2004
34Transcription Factors (Transcription Factor)IBA
03/2024 - 04/2002
34Small Interfering RNA (siRNA)IBA
02/2024 - 09/2009
33Indicators and Reagents (Reagents)IBA
04/2024 - 01/2008
33VaccinesIBA
02/2024 - 12/2002
32CholesterolIBA
04/2024 - 01/2004
31AntibodiesIBA
02/2024 - 05/2003
31CateninsIBA
08/2023 - 08/2011
29Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 12/2005
28Antiviral Agents (Antivirals)IBA
04/2024 - 07/2009
27Circular RNAIBA
05/2024 - 01/2018
27LipopolysaccharidesIBA
05/2024 - 09/2010
25Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2024 - 06/2013
25AlbuminsIBA
12/2023 - 01/2011
25LigandsIBA
11/2023 - 05/2003

Therapy/Procedure

484Therapeutics
05/2024 - 10/2002
183Drug Therapy (Chemotherapy)
05/2024 - 11/2003
92Immunotherapy
05/2024 - 02/2003
90Radiotherapy
05/2024 - 08/2003
50Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 09/2007
34Transplantation
05/2024 - 08/2003
29Neoadjuvant Therapy
04/2024 - 01/2008
28Lasers (Laser)
03/2023 - 10/2002
26Aftercare (After-Treatment)
05/2024 - 10/2004
26Ligation
03/2024 - 03/2003